Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
BCNU SUSTAINED-RELEASE IMPLANT FOR TREATING SOLID TUMOR AND PREPARATION METHOD THEREOF
Document Type and Number:
WIPO Patent Application WO/2016/095592
Kind Code:
A1
Abstract:
A BCNU sustained-release implant for treating solid tumor and preparation method thereof, the sustained-release implant comprising a sustained-release excipient and an effective anti-cancer ingredient BCNU; the sustained-release excipient is made from a copolymer of lactide and glycolide having a viscosity in a range of 0.3-0.6 dl/g; the percentage by weight of the BCNU is 7.5%-30%; the mass ratio of lactide to glycolide is (25-75) : (75-25). The implant is applied to treat solid tumors such as pancreatic cancer, lung cancer and the like, and liver and brain metastatic tumors.

Inventors:
KONG QINGZHONG (CN)
WEI MINGXING (CN)
SU HONGQING (CN)
WU SONGZHI (CN)
YU JIANJIANG (CN)
JIANG JUNMIN (CN)
LI ZHAOWEN (CN)
Application Number:
PCT/CN2015/091049
Publication Date:
June 23, 2016
Filing Date:
September 29, 2015
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANDONG LANJIN PHARMACEUTICALS CO LTD (CN)
International Classes:
A61K9/00; A61K31/175; A61K47/34
Foreign References:
CN104523566A2015-04-22
CN1698592A2005-11-23
CN101176713A2008-05-14
Attorney, Agent or Firm:
JINAN JINDI INTELLECTUAL PROPERTY AGENCY CO., LTD (CN)
济南金迪知识产权代理有限公司 (CN)
Download PDF: